Université de Bordeaux
OptoPath™
Cluster of excellence
Presentation of the project OptoPath™

A rodent platform entirely dedicated to innovation in experimental psychopathology

OptoPath™ combines the expertise of neurobiologists, electrophysiologists and experimental psychologists for the identification of new therapeutic targets against 4 major psychological disorders: Addiction, Obesity, PTSD/Anxiety-related disorders and Memory deficits.

Combining innovative animal models and cutting-edge technologies, OptoPath provides :

  • A large range of in vivo assays to evaluate the safety/therapeutic effects of novel drugs in the context of 4 major psychopathologies:

ADDICTION

OBESITY

 PTSD-ANXIETY MEMORY DEFICITS
450
M2
34
Neurobiology
units
116
Behavioral
units
+40
Users
Headline News OptoPath™
OPTOPATH BECOMES MEMBER OF NEUROSERVICE ALLIANCE23/07OPTOPATH BECOMES MEMBER OF NEUROSERVICE ALLIANCE

Neuroservices-Alliance is a One Stop Shop CNS CRO, providing pharmaceutical industries with functional readouts in neuro-pharmacology. The various CNS platforms members of Neuroservices-Alliance allow industrial clients to benefit from complementary data, generated from in vitro & in vivo CNS Electrophysiology and Behavioral tests. Neuroservices-Alliance is a CNS and Pain research programs accelerator empowered by a strong college of experts.

Share on   
[ read more ]
more news
TOP